Establishment of the haemopoietic transcriptional programme: From systems approaches to molecular mechanisms

造血转录程序的建立:从系统方法到分子机制

基本信息

  • 批准号:
    BB/I001220/1
  • 负责人:
  • 金额:
    $ 225.28万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

Our genes control how our body develops from one fertilized egg cell and all cells in our body contain the same set of genes. This cell rapidly divides and develops into a large variety of distinct cell types that make up the various organs in our body. All these cells express different genetic programs, meaning that not all of our genes are always active in every cell type. This cell-type-specific gene activation pattern is governed by another layer of control (on top of the layer of the genes) that tells cells which genes to switch on and off, thereby deciding which cell type develops. This additional control layer is called the 'epigenetic' layer and consists of two components: (1) a genome-wide network through which genes regulate each other to generate the appropriate gene expression patterns; (2) the DNA packing apparatus. Each cell contains one meter of DNA, and to be able to fit it into the nucleus, it is densely compacted by so called chromatin proteins such that inactive genes are highly compact and their DNA hidden, whereas active genes are in areas of reduced compaction. To activate an inactive, compact gene, protein complexes, so called 'transcription factors' push chromatin aside or modify it, so that genes become accessible to the factors that activate them. Studies in the past years focused on one gene at a time and led to the discovery of the transcription factors and chromatin components that control their activity. We learned to extract the tune that individual genes play but failed to hear the symphony. Our understanding of how all the genes in mammals are orchestrated to switch on and off in the right order is still superficial. Moreover, much of what we know is based on studies from cell lines, which represent fixed cell types or are cancer cells, and from simpler organisms, such as yeast. The situation in mammals is much more complex because building an organism from a fertilized egg involves turning one cell type into another (so called 'differentiation') in a precise hierarchical order which requires tight coordination of the activity of all the genes. In other words, building an organism is like building a house: we have to put the individual components together in a precise order and not start with the roof before the cellar. This proposal will use blood cell development in the mouse as a model to investigate the dynamics of cell differentiation in mammals. We will study all genes of a given cell type and use a sophisticated in vitro system based on embryonic stem cells where we can generate and purify different blood cell types. We then will identify which transcription factors and chromatin components regulate which genes at the different developmental stages and study at which level and when they are expressed. Until recently such global or 'systems biology' studies were beyond reach since the technology was lacking. However, with the latest technology we can determine the entire DNA sequence of one cell type in a very short time. This technology has been modified to study epigenetic changes at all genes and can now be used to identify what distinguishes genes of one cell type from those of another. However, one feature of such experiments is that they produce enormous amounts of data and require specialist knowledge to make sense of them. This is achieved by bioinformaticians developing new computer programs and mathematical modelers running simulations to predict the integrated, 'collective' behavior of genes. To this end we have formed an interdisciplinary consortium consisting of experimental researchers and computational biologists who will collaborate to understand how thousands of genes work together to generate specific cell types. The ultimate aim of these studies is to be able to understand how individual development is encoded in the DNA-sequence and to predict how changes in the DNA sequence impact on developmental processes.
我们的基因控制着我们的身体如何从一个受精的卵细胞发育而来,我们身体中的所有细胞都包含一套相同的基因。这种细胞迅速分裂并发育成多种不同的细胞类型,这些细胞类型组成了我们身体的各种器官。所有这些细胞都表达不同的遗传程序,这意味着并不是所有的基因在每种细胞类型中都是活跃的。这种特定于细胞类型的基因激活模式由另一层控制(在基因层的顶部)控制,它告诉细胞打开和关闭哪些基因,从而决定哪种细胞类型的发育。这个额外的控制层被称为表观遗传层,由两个组成部分组成:(1)全基因组网络,通过这个网络,基因相互调节,产生适当的基因表达模式;(2)DNA包装装置。每个细胞含有一米长的DNA,为了能够将其装入细胞核,它被所谓的染色质蛋白质密集地压缩,使得不活跃的基因高度紧凑,其DNA被隐藏,而活跃的基因位于压缩程度较低的区域。为了激活一个不活跃的、紧凑的基因,蛋白质复合体,即所谓的“转录因子”,将染色质推到一边或修改它,这样激活基因的因子就可以访问它们。在过去的几年里,研究集中在一个基因上,并导致了控制其活性的转录因子和染色质成分的发现。我们学会了提取单个基因演奏的曲调,但听不到交响乐。我们对哺乳动物的所有基因如何以正确的顺序开启和关闭的理解仍然很肤浅。此外,我们所知道的大部分是基于对代表固定细胞类型或癌细胞的细胞系的研究,以及来自更简单的生物体的研究,如酵母。哺乳动物的情况要复杂得多,因为从受精卵构建有机体需要按照精确的等级顺序将一种细胞类型转变为另一种细胞类型(所谓的“分化”),这需要所有基因的活动紧密协调。换句话说,建造有机体就像建造一座房子:我们必须按精确的顺序将单个组件组合在一起,而不是从屋顶开始,然后再从地下室开始。这项建议将以小鼠的血细胞发育为模型,研究哺乳动物细胞分化的动力学。我们将研究给定细胞类型的所有基因,并使用基于胚胎干细胞的复杂体外系统,在那里我们可以产生和纯化不同类型的血细胞。然后,我们将确定哪些转录因子和染色质成分调节不同发育阶段的哪些基因,并研究它们在什么水平和何时表达。直到最近,由于缺乏这项技术,这样的全球或“系统生物学”研究还遥不可及。然而,有了最新的技术,我们可以在很短的时间内确定一种细胞类型的整个DNA序列。这项技术已经被改进,可以研究所有基因的表观遗传学变化,现在可以用来识别一种细胞类型的基因与另一种细胞类型的基因的区别。然而,这类实验的一个特点是它们产生了大量的数据,需要专业知识才能理解它们。这是通过生物信息学家开发新的计算机程序和数学模型来实现的,这些计算机程序和数学模型运行模拟来预测基因的整合的“集体”行为。为此,我们成立了一个由实验研究人员和计算生物学家组成的跨学科联盟,他们将合作了解数千个基因如何共同作用来产生特定的细胞类型。这些研究的最终目的是能够理解个体发育是如何在DNA序列中编码的,并预测DNA序列的变化如何影响发育过程。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation.
  • DOI:
    10.1016/j.devcel.2016.01.024
  • 发表时间:
    2016-03-07
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    Goode DK;Obier N;Vijayabaskar MS;Lie-A-Ling M;Lilly AJ;Hannah R;Lichtinger M;Batta K;Florkowska M;Patel R;Challinor M;Wallace K;Gilmour J;Assi SA;Cauchy P;Hoogenkamp M;Westhead DR;Lacaud G;Kouskoff V;Göttgens B;Bonifer C
  • 通讯作者:
    Bonifer C
Cooperative binding of AP-1 and TEAD4 modulates the balance between vascular smooth muscle and hemogenic cell fate.
  • DOI:
    10.1242/dev.139857
  • 发表时间:
    2016-12-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Obier N;Cauchy P;Assi SA;Gilmour J;Lie-A-Ling M;Lichtinger M;Hoogenkamp M;Noailles L;Cockerill PN;Lacaud G;Kouskoff V;Bonifer C
  • 通讯作者:
    Bonifer C
RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis.
  • DOI:
    10.1038/emboj.2012.275
  • 发表时间:
    2012-11-14
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Lichtinger, Monika;Ingram, Richard;Hannah, Rebecca;Mueller, Dorothee;Clarke, Deborah;Assi, Salam A.;Lie-A-Ling, Michael;Noailles, Laura;Vijayabaskar, M. S.;Wu, Mengchu;Tenen, Daniel G.;Westhead, David R.;Kouskoff, Valerie;Lacaud, Georges;Goettgens, Berthold;Bonifer, Constanze
  • 通讯作者:
    Bonifer, Constanze
Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
转录因子 PAX5 对 B 细胞中 Csf1R 位点有义和反义启动子活性的差异调节。
  • DOI:
    10.1016/j.exphem.2011.04.004
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Ingram RM
  • 通讯作者:
    Ingram RM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Constanze Bonifer其他文献

3113 – LEUKAEMIC STEM CELLS CELL HIJACK LINEAGE INAPPROPRIATE SIGNALLING PATHWAYS TO ACTIVATE GROWTH
  • DOI:
    10.1016/j.exphem.2022.07.169
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sophie Kellaway;Sandeep Potluri;Luke Ames;Peter Keane;Paulynn Chin;Anetta Ptasinska;Salam Assi;Alice Worker;Helen Blair;Olaf Heidenreich;Peter Cockerill;Constanze Bonifer
  • 通讯作者:
    Constanze Bonifer
Declined presentation the pattern of aberrant chromatin programming in acute myeloid leukemia is determined by the mutational landscape
  • DOI:
    10.1016/j.exphem.2017.06.308
  • 发表时间:
    2017-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Constanze Bonifer;Ching Ting Justin Loke;Salam Assi;Maria Rosaria Imperato;Anetta Ptasinska;Anna Pickin;Pierre Cauchy;Natalja Martinez-Soria;Paulynn Chin;Olaf Heidenreich;Peter Cockerill
  • 通讯作者:
    Peter Cockerill
Integrated analyses of chromatin accessibility and gene expression data for elucidating the transcriptional regulatory mechanisms during early hematopoietic development in mouse
  • DOI:
    10.1186/1756-8935-6-s1-p50
  • 发表时间:
    2013-03-01
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Mahalingam S Viiavabaskar;Nadine Obier;Stella Pearson;Maarten Hoogenkamp;Monika Lichtinger;Georges Lacaud;Valerie Kouskoff;Bertie Gottgens;Constanze Bonifer;David R Westhead
  • 通讯作者:
    David R Westhead
Identification of a dynamic core transcriptional regulatory network for t(8;21) AML
  • DOI:
    10.1016/j.exphem.2013.05.061
  • 发表时间:
    2013-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anetta Ptasinska;Salam Assi;Dan Williamson;Pierre Cauchy;Daniel Tenen;Peter Cockerill;David Westhead;Olaf Heidenreich;Constanze Bonifer
  • 通讯作者:
    Constanze Bonifer
3075 - Phenotypic and Transcriptomic Analysis of the Disruption of Embryonic Hematopoietic Development by A Panel of RUNX1 Mutants
  • DOI:
    10.1016/j.exphem.2018.06.261
  • 发表时间:
    2018-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sophie Kellaway;Regha Kakkad;Peter Keane;Salam Assi;Constanze Bonifer
  • 通讯作者:
    Constanze Bonifer

Constanze Bonifer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Constanze Bonifer', 18)}}的其他基金

Finding therapeutic targets in FLT3-ITD AML using a systems biology approach
使用系统生物学方法寻找 FLT3-ITD AML 的治疗靶点
  • 批准号:
    MR/S021469/1
  • 财政年份:
    2019
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
UNDERSTANDING THE INTERPLAY OF ENHANCERS, CHROMATIN PRIMING ELEMENTS AND SIGNALS REGULATING DYNAMIC GENE EXPRESSION IN DEVELOPMENT
了解增强子、染色质启动元件和发育过程中动态基因表达调节信号的相互作用
  • 批准号:
    BB/R014809/1
  • 财政年份:
    2018
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
MECHANISTIC INSIGHTS INTO THE DEVELOPMENTAL-STAGE SPECIFIC ACTIVITY OF A UBIQUITOUSLY EXPRESSED TRANSCRIPTION FACTOR
对普遍表达的转录因子的发育阶段特异性活性的机制见解
  • 批准号:
    BB/M020800/1
  • 财政年份:
    2015
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
Establishment of the haemopoietic transcriptional programme: From systems approaches to molecular mechanisms
造血转录程序的建立:从系统方法到分子机制
  • 批准号:
    BB/I001220/2
  • 财政年份:
    2011
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
The role of the transcription factor Sp1 in embryonic macrophage development
转录因子Sp1在胚胎巨噬细胞发育中的作用
  • 批准号:
    G0901579/2
  • 财政年份:
    2011
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
The role of the transcription factor Sp1 in embryonic macrophage development
转录因子Sp1在胚胎巨噬细胞发育中的作用
  • 批准号:
    G0901579/1
  • 财政年份:
    2010
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
Developing methods and bioinformatics tools for the global analysis of accessible regions in chromatin
开发用于染色质可及区域全局分析的方法和生物信息学工具
  • 批准号:
    BB/F02441X/1
  • 财政年份:
    2008
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
Mechanistic insights into priming and early gene activation processes in the haemopoietic system
对造血系统启动和早期基因激活过程的机制见解
  • 批准号:
    BB/E025129/1
  • 财政年份:
    2008
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant
Improving the specificity and throughput of automated analysis of chromatin fine structure in eukaryotic cells
提高真核细胞染色质精细结构自动分析的特异性和通量
  • 批准号:
    BB/E005640/1
  • 财政年份:
    2006
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Research Grant

相似海外基金

Regulation of Haemopoietic and Immune Cells in Health and Disease
健康和疾病中造血细胞和免疫细胞的调节
  • 批准号:
    nhmrc : GNT1113577
  • 财政年份:
    2017
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Programs
Regulation of Haemopoietic and Immune Cells in Health and Disease
健康和疾病中造血细胞和免疫细胞的调节
  • 批准号:
    nhmrc : 1113577
  • 财政年份:
    2017
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Program Grants
Heterogeneity within the ageing human haemopoietic compartment and predisposition to cancer
衰老人类造血室内的异质性和癌症易感性
  • 批准号:
    1951732
  • 财政年份:
    2017
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Studentship
Patient tailored anti-tumour T cells to prevent relapse in patients with acute myeloid leukaemia undergoing allogeneic haemopoietic stem cell transplantation
为患者量身定制抗肿瘤T细胞,以预防接受同种异体造血干细胞移植的急性髓系白血病患者复发
  • 批准号:
    nhmrc : GNT1089398
  • 财政年份:
    2015
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Early Career Fellowships
Patient tailored anti-tumour T cells to prevent relapse in patients with acute myeloid leukaemia undergoing allogeneic haemopoietic stem cell transplantation
为患者量身定制抗肿瘤T细胞,以预防接受同种异体造血干细胞移植的急性髓系白血病患者复发
  • 批准号:
    nhmrc : 1089398
  • 财政年份:
    2015
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Early Career Fellowships
Bone marrow Endothelial Stem Cells have the capacity to form both the endothelial and haemopoietic hierarchies
骨髓内皮干细胞具有形成内皮和造血层次结构的能力
  • 批准号:
    nhmrc : GNT1084990
  • 财政年份:
    2015
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Project Grants
Bone marrow Endothelial Stem Cells have the capacity to form both the endothelial and haemopoietic hierarchies
骨髓内皮干细胞具有形成内皮和造血层次结构的能力
  • 批准号:
    nhmrc : 1084990
  • 财政年份:
    2015
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Project Grants
A clinical trial of partially HLA-matched unrelated donor microtransplantation for prevention of relapse in patients with acute myeloid leukaemia ineligible for standard haemopoietic stem cell transplantation
部分 HLA 匹配的无关供体微移植预防不适合标准造血干细胞移植的急性髓系白血病患者复发的临床试验
  • 批准号:
    nhmrc : 1061252
  • 财政年份:
    2014
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Project Grants
Investigating a novel role for the haemopoietic growth factor receptor, c-Mpl, in regulating shear-dependent platelet adhesive function
研究造血生长因子受体 c-Mpl 在调节剪切依赖性血小板粘附功能中的新作用
  • 批准号:
    nhmrc : 1066956
  • 财政年份:
    2014
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Project Grants
MECHANISMS IN HAEMOPOIETIC DIFFERENTIATION: INSIGHTS FROM NOVEL LOCI IN GENETIC THROMBOCYTOPENIA
造血分化机制:来自遗传性血小板减少症新基因座的见解
  • 批准号:
    MR/K023489/1
  • 财政年份:
    2013
  • 资助金额:
    $ 225.28万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了